These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 25402585)
1. Advances in MRI biomarkers for the diagnosis of Alzheimer's disease. Kehoe EG; McNulty JP; Mullins PG; Bokde AL Biomark Med; 2014; 8(9):1151-69. PubMed ID: 25402585 [TBL] [Abstract][Full Text] [Related]
2. Seven-Tesla MRI and neuroimaging biomarkers for Alzheimer's disease. Ali R; Goubran M; Choudhri O; Zeineh MM Neurosurg Focus; 2015 Nov; 39(5):E4. PubMed ID: 26646928 [TBL] [Abstract][Full Text] [Related]
3. The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques. Li TQ; Wahlund LO Acta Radiol; 2011 Mar; 52(2):211-22. PubMed ID: 21498351 [TBL] [Abstract][Full Text] [Related]
4. Improved Diagnostic Accuracy of Alzheimer's Disease by Combining Regional Cortical Thickness and Default Mode Network Functional Connectivity: Validated in the Alzheimer's Disease Neuroimaging Initiative Set. Park JE; Park B; Kim SJ; Kim HS; Choi CG; Jung SC; Oh JY; Lee JH; Roh JH; Shim WH; Korean J Radiol; 2017; 18(6):983-991. PubMed ID: 29089831 [TBL] [Abstract][Full Text] [Related]
5. Quantitative MRI to understand Alzheimer's disease pathophysiology. Bozzali M; Serra L; Cercignani M Curr Opin Neurol; 2016 Aug; 29(4):437-44. PubMed ID: 27228309 [TBL] [Abstract][Full Text] [Related]
6. Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models. Kincses ZT; Király A; Veréb D; Vécsei L J Alzheimers Dis; 2015; 47(2):277-90. PubMed ID: 26401552 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging based clinical research in Alzheimer's disease. Fayed N; Modrego PJ; Salinas GR; Gazulla J J Alzheimers Dis; 2012; 31 Suppl 3():S5-18. PubMed ID: 22233763 [TBL] [Abstract][Full Text] [Related]
9. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364 [TBL] [Abstract][Full Text] [Related]
10. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Ten Kate M; Barkhof F; Boccardi M; Visser PJ; Jack CR; Lovblad KO; Frisoni GB; Scheltens P; Neurobiol Aging; 2017 Apr; 52():167-182.e1. PubMed ID: 28317647 [TBL] [Abstract][Full Text] [Related]
11. [Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms]. Villain N; Chételat G; Desgranges B; Eustache F Biol Aujourdhui; 2010; 204(2):145-58. PubMed ID: 20950559 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic. Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634 [TBL] [Abstract][Full Text] [Related]
13. Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials. Menéndez-González M; de Celis Alonso B; Salas-Pacheco J; Arias-Carrión O J Alzheimers Dis; 2015; 48(3):581-9. PubMed ID: 26402089 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging for diagnosis of early Alzheimer's disease. Colliot O; Hamelin L; Sarazin M Rev Neurol (Paris); 2013 Oct; 169(10):724-8. PubMed ID: 24011982 [TBL] [Abstract][Full Text] [Related]
15. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578 [TBL] [Abstract][Full Text] [Related]
16. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]
17. Medial temporal lobe high resolution magnetic resonance images for the early diagnosis of Alzheimer's disease. Brun F; Sensi F; Quartulli R; Rei L; Grucka A; Mancarella V; Chincarini A; Ukmar M; Accardo A; Longo R Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():4274-7. PubMed ID: 26737239 [TBL] [Abstract][Full Text] [Related]
18. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers. Chételat G; Fouquet M Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463 [TBL] [Abstract][Full Text] [Related]
19. In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature. Lener MS; Iosifescu DV Ann N Y Acad Sci; 2015 May; 1344():50-65. PubMed ID: 25854817 [TBL] [Abstract][Full Text] [Related]
20. The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Davis PC; Gearing M; Gray L; Mirra SS; Morris JC; Edland SD; Lin T; Heyman A Neurology; 1995 Jan; 45(1):178-9. PubMed ID: 7824112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]